Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-04-29

Clinical Trial Update: A Trial of Generic Substitution of Antiepileptic Drugs [Phase 4]

View source ↗

Summary

The document describes a Phase 4 clinical trial evaluating generic substitution of antiepileptic drugs for epilepsy, sponsored by the IRCCS National Neurologica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: IRCCS National Neurological Institute "C. Mondino" Foundation | Conditions: Epilepsy | Phase 4 | Status: UNKNOWN